U.S. Infrastructure Stock News

Earlier this week, Evercore ISI initiated coverage of Credo Technology Group Holding with an Outperform rating, emphasizing its move beyond copper-based AI connectivity into optical DSPs and silicon photonics following the DustPhotonics acquisition. This coverage spotlighted how Credo’s expanded optical portfolio and vertically integrated technology stack could materially reshape its role in future AI data-center networking architectures. With this backdrop, we’ll now examine how Evercore’s...

Mastercard and JD.com have agreed to a new partnership focused on payment infrastructure, cross-border commerce, and AI-supported purchasing. The collaboration targets areas such as fraud prevention, SME supply chain finance, and co-branded card programs. This development positions Mastercard to deepen its role in digital commerce across Asia and within JD.com’s ecosystem. Mastercard, traded on NYSE:MA, is adding another major ecommerce partner as it looks to remain central to global...

Canadian Solar (CSIQ) has drawn fresh attention after unveiling its TOPCon 3.0 high-power-density photovoltaic module, a product aimed at large utility projects and commercial or industrial rooftops worldwide. See our latest analysis for Canadian Solar. The TOPCon 3.0 announcement arrives after a mixed period for Canadian Solar, with the share price at US$16.27, a 30 day share price return down 13.82% but a 90 day share price return up 22.7%. The 1 year total shareholder return is 60.61%,...

KLA (KLAC) drew fresh attention after announcing a ten-for-one stock split, paired with stronger AI-driven semiconductor demand and rising institutional interest. This has prompted many investors to reassess the stock’s recent performance and valuation. See our latest analysis for KLA. Recent gains have been sharp, with KLA’s share price up 8.73% in the last session, 37.45% over 30 days and 103.66% year to date. Its 1 year total shareholder return of 205.08% and 5 year total shareholder...

Recently, Signet Jewelers received a favorable Zacks Rank #2 (Buy) and an A grade for value, reflecting valuation metrics that compare attractively with industry averages. This recognition highlights how analyst views on Signet’s earnings outlook and perceived undervaluation are becoming an increasingly important part of the investment story. We’ll now examine how this positive analyst stance on Signet’s valuation and earnings outlook aligns with, or challenges, its existing investment...

BridgeBio Pharma announced that it will present additional positive data from its pivotal Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia, along with multiple clinical and quality-of-life studies in skeletal dysplasias and autosomal dominant hypocalcemia, at the International Congress of Children’s Bone Health 2026 in Montreal. By pairing late-breaking Phase 3 efficacy data with real-world quality-of-life, early intervention, and disease-burden findings, BridgeBio...

CoreWeave (CRWV) has drawn fresh attention after recent trading, with the stock closing at $117.95. Investors are weighing this move alongside the company’s role in providing cloud infrastructure for artificial intelligence workloads. See our latest analysis for CoreWeave. That US$117.95 close caps a strong run, with a 1 day share price return of 2.38% and a 90 day share price return of 42.07%. However, the 1 year total shareholder return is down 32.09%, so momentum in CoreWeave’s share price...

Teradyne was recently added to the Nasdaq-100 Index, while simultaneously benefiting from heightened demand for its semiconductor test equipment and robotics tied to AI infrastructure and defense applications. Alongside its index inclusion, Teradyne’s multi-year U.S. Air Force contract and collaboration with Tokyo Electron highlight its role in enabling AI-focused semiconductor testing. We’ll now explore how Teradyne’s Nasdaq-100 inclusion could influence its investment narrative built...

Taysha Gene Therapies (TSHA) has drawn fresh attention after completing patient dosing in its pivotal REVEAL trial of TSHA-102 for Rett syndrome and sharing longer-term safety and functional outcome data. See our latest analysis for Taysha Gene Therapies. The Rett data release has arrived alongside a sharp shift in how the market prices Taysha Gene Therapies, with a 30 day share price return of 16.94% and a year to date share price return of 22.29%. The 1 year total shareholder return of...

Golar LNG (NasdaqGS:GLNG) has attracted fresh attention after recent share price moves, with the stock trading around $49.60. Investors are weighing its liquefied natural gas infrastructure focus in relation to its mixed short term return figures. See our latest analysis for Golar LNG. Recent share price moves around $49.60 come after a year where Golar LNG’s share price return is up 30.70% year to date, while the 3 year total shareholder return of 170.90% and 5 year total shareholder return...

Turning Point Brands (TPB) is back in focus after recent data showed a sharp rise in institutional ownership, with investors such as BlackRock and Thrivent Asset Management expanding positions and helping lift the company to a leading position within the Food & Tobacco industry. See our latest analysis for Turning Point Brands. Turning Point Brands’ share price has been under pressure recently, with the stock down 8.86% over the past month and 25.60% year to date. At the same time, 1-year...

Rexford Industrial Realty (REXR) drew fresh attention after Scotiabank raised its recommendation on the stock, coinciding with rising institutional ownership and increased positioning by the company’s largest institutional shareholder. See our latest analysis for Rexford Industrial Realty. At a share price of $33.12, Rexford Industrial Realty has seen its 1 day share price return of 2.0% partially offset a weaker recent patch, with the 30 day share price return down 8.46% and the 1 year total...

Astrana Health, Inc. recently filed a shelf registration for up to US$38.73 million, covering 1,000,000 shares of common stock for an ESOP-related offering. This move, coming alongside a recent analyst upgrade citing an improved outlook for value-based care, underscores Astrana’s focus on employee ownership and operational momentum. We’ll now examine how Barclays’ more constructive view on Astrana’s value-based care outlook may influence the company’s broader investment narrative. Explore 31...

Export oriented Indian industrials are in the spotlight as U.S. tariff decisions approach, with expiry of key import tariffs on July 24 and potential new Section 301 measures adding a fresh layer of uncertainty to India U.S. trade. For investors looking at this theme, the question is whether selected exporters with solid health and growth profiles can still offer resilient opportunities if policy turns less friendly. This article breaks down 3 stocks from the Export Oriented Indian...

Flowserve (FLS) is back in focus as investors react to its greater push into higher margin service and digital monitoring offerings tied to critical energy and water infrastructure projects. See our latest analysis for Flowserve. Recent trading reflects that shift in focus, with the share price up 17.37% over the past 30 days and 15.48% year to date, while Flowserve’s 1 year total shareholder return of 78.44% and 3 year total shareholder return of 136.79% point to strong momentum rather than...

Venture Global (NYSE:VG) has signed new and expanded LNG supply agreements with Germany's EnBW and Greece’s Atlantic-SEE. The Atlantic-SEE contract has been doubled, increasing Venture Global's contracted LNG volumes into Europe. These agreements deepen the company's role as a U.S. LNG supplier to European utilities focused on long-term energy diversification. Venture Global is a U.S. liquefied natural gas exporter, and its latest deals with EnBW and Atlantic-SEE add fresh detail to how the...

Definium Therapeutics (DFTX) reported that its Phase 3 Emerge trial of DT120 Orally Disintegrating Tablet in adults with major depressive disorder met the primary and all key secondary efficacy endpoints, highlighting clinically meaningful differences versus placebo. See our latest analysis for Definium Therapeutics. Definium Therapeutics’ positive Phase 3 Emerge data lands after a strong run in the stock, with a 30 day share price return of 8.8% and a 90 day share price return of 37.61%,...

Erasca, Inc. is now the subject of multiple securities class action lawsuits alleging misleading statements about its lead oncology candidate ERAS-0015, including claims of undisclosed safety concerns, questionable efficacy comparisons, and heightened patent and trade secret risks, following disclosures made prior to today. The convergence of alleged data misrepresentation, intellectual property disputes with Revolution Medicines, and a reported patient death has turned ERAS-0015 from a core...

Remitly Global recently integrated Colombia’s national instant payment system Bre-B, backed by Banco de la República, into its remittance network, enabling customers to send money instantly to recipients identified by phone number, email address, or national ID. This expansion of Remitly’s payout infrastructure in Colombia highlights how technology partnerships can deepen penetration in key corridors and potentially enhance user convenience and transaction throughput. Next, we’ll examine...

Earlier this month, BlackRock announced the launch of the iShares Bitcoin Premium Income ETF (Nasdaq: BITA), an exchange-traded product that combines spot bitcoin and IBIT exposure with a covered call options strategy to seek monthly option premium distributions. The product’s structure, which blends direct bitcoin holdings, IBIT options, and partnership tax features, highlights BlackRock’s effort to pair digital asset access with income generation and potential tax efficiencies for...

Global inflation stories, shifting bond yields and mixed consumer signals in Europe and Asia are keeping risk assets on their toes. At the same time, they also put steady, contract driven businesses like Aerospace and Defense companies firmly on many investors’ watchlists. This Aerospace And Defense screener focuses on companies that manufacture or provide services to the sector. Many investors view these companies as a way to seek more predictable demand tied to long term government and...

Earlier in June 2026, McEwen Inc. released a Pre-Feasibility Study for its 100%-owned Grey Fox Project near Timmins, Ontario, outlining a 15-year mine life, initial capital spending of US$181 million, and plans to use existing Fox Complex processing infrastructure. The study indicates Grey Fox could become a core ore source for the Fox Complex, materially extending mine life while targeting meaningful cash flow generation at modeled gold prices, supported by a sizeable indicated resource...

Amazon.com (AMZN) is under pressure after heavy AI infrastructure spending cut free cash flow and raised questions about how quickly those investments translate into returns, even as Prime Day expectations and institutional interest remain supportive. See our latest analysis for Amazon.com. Against this backdrop of heavier AI spending and Prime Day headlines, Amazon.com’s 1 month share price return is down 8.23% and its year to date share price return is 7.90%. The 1 year total shareholder...

Recent coverage of China Yuchai International (NYSE:CYD) has focused on a sharp year-over-year net profit decline, a weak sector financial ranking, and predominantly sell signals across technical indicators, even as institutional ownership has risen. See our latest analysis for China Yuchai International. At a latest share price of $48.70, China Yuchai International has pulled back sharply in the past month, with the 30 day share price return down 15.08%, even after a 31.55% share price...